BioCryst Launches ORLADEYO (berotralstat) in Italy

19.02.2024 - RESEARCH TRIANGLE PARK, N.C., Feb. 19, 2024 (GLOBE NEWSWIRE) - BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Italian Medicines Agency, Agenzia Italiana del Farmaco (AIFA), has finalized reimbursement and recommended ...

Related Keywords

Italy ,Italian ,Charlie Gayer ,Nasdaq ,Biocryst Pharmaceuticals Inc ,Italian Medicines Agency ,Cryst Pharmaceuticals ,Agenzia Italiana Del Farmaco ,Biocryst Pharmaceuticals Chart ,Iocryst Pharmaceuticals Kurs ,Iocryst Pharmaceuticals Aktie ,